Z-Med is a technology-oriented DIH that focuses on the application of certain technologies to address a sectoral or multisectoral challenge such as the use of AI in healthcare and related industries. Z-Med also supports sector-specific activities that may be narrower than the health sector in general. It is also a platform for ecosystem creation that unites multiple stakeholders, healthcare institutions, academia and the education system, and entrepreneurs.
Z-MED is an organizational part of PCKZŽ. Organizational and administrative support will be provided by PCKZŽ employees in cooperation with the partners, and one of the partners is BICRO BIOCentre Ltd.
AREAS OF ACTIVITIES
Providing health services
- Remote medicine (telemedicine)
- Greater access to health care (rich vs. poor, urban vs. rural)
- Supply chain resilience
- Transparency in supply chains (upstream and downstream)
- Patient care focused on outpatient treatment – self-diagnosis and continuous remote monitoring
support home care or in outpatient clinics
- Personalized medicine
Medical engineering (implants and prostheses) and devices
- Minimally invasive devices
- Personal portable electronic devices (consumer wareable)
- Outsourcing the development of medical devices
- Nanotechnology
Digitalization
- Medical technology in general is becoming "smart"
- Digitization of the process of education of health professionals
- High-performance computers for the application of AI in drug development and diagnostics
- Robotics and operations
- Telemedicine
- Genomics and bio-informatics
Bio-M
- Identification and quantification of active and auxiliary pharmaceutical substances, preservatives, antioxidants and their contaminants
- Development of stability-indicative analytical methods for finished drugs
- Development of methods for monitoring the validation of cleaning of production facilities after drug production
- Identification and quantification of protein molecules
- Isolation of individual contaminants above the specification limit, isolation and purification of specific bioactive components, production and purification of recombinant proteins (µg to mg), and development of protein production processes, biopharmaceuticals and bio-similar drugs
- Cultivation, maintenance and storage of bacterial and yeast cultures
- Cell culture and expression of recombinant proteins on a laboratory and semi-industrial scale in bioreactor systems
- Process development and cell bank management
More about Z-MED please read here https://poduzetnickicentar-kzz.hr/z-med-en/